MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Inflammatory Bowel Disease
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,452 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,452 works in the cohort · of 4,299,418page 56 of 130

Labels cover 21 of 6,452 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,452 of 6,452 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Clinical Guidelines for the Management of IBD
Reena Khanna, Aze Wilson, James C. Gregor, Katherine L. Prowse, Waqqas Afif
2021· article· en· Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Prevention of relapse of Crohn's disease
Lloyd R. Sutherland
2000· review· en· Inflammatory Bowel Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
aboutno affunlabeled
Chronic inflammation and other changes are significant components of clinically fibrotic strictures in Crohn’s disease: a histological study of resected strictures clinically characterized as noninflamed
Uday N. Shivaji, Matthew Evans, T Critchlow, Xianyong Gui, Samuel C. Smith, Thomas Pinkney +4 more
2020· article· en· European Journal of Gastroenterology & Hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Séverine Vermeire, Silvio Danese +9 more
2024· article· en· Alimentary Pharmacology & Therapeutics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Severe stricturing Crohn's disease of the duodenum
Jennifer M. Racz, Ward Davies
2012· article· en· International Journal of Surgery Case Reports· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Ustekinumab for the treatment of Crohn’s disease
Tawnya Hansen, Laura E. Targownik
2016· review· en· Expert Review of Gastroenterology & Hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Biomarkers That Predict Crohn’s Disease Outcomes
Pablo A. Olivera, Mark S. Silverberg
2023· article· en· Journal of the Canadian Association of Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Ustekinumab: a novel therapeutic option in Crohn’s disease
Ebby George Simon, S. Samuel, Subrata Ghosh, Gordon W. Moran
2016· review· en· Expert Opinion on Biological Therapy· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
afffundunlabeled
It’s Time to Change Tack in IBD Treatment
Marcel A. Behr, Ildiko Mehes, Charles N. Bernstein
2024· article· en· Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Disease Clearance in Ulcerative Colitis: A Narrative Review
Silvio Danese, Laurent Peyrin‐Biroulet, Vipul Jairath, Ferdinando D’Amico, Shashi Adsul, Christian Agboton +1 more
2025· review· en· United European Gastroenterology Journal· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
P300 Health related quality of life results through week 22 from the CERTIFI study, a multicenter, randomized, double-blind, placebo-controlled Phase2b study of ustekinumab in patients with moderately to severely active Crohn's disease
B. Feagan, Christopher Gasink, Ling Gao, Mikhail Blank, Jewel Johanns, Cynthia Guzzo +12 more
2012· article· en· Journal of Crohn s and Colitis· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
9
citations
affno abstractunlabeled
Mild to Moderate Crohn’s Disease
Karen K. Wong, Brian Bressler
2008· review· en· Drugs· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
9
citations

How this was built: Screen · Findings · About